| Bristol-Myers Squibb SA - Empliciti 300 mg, Pulver zur Herstellung einer Infusionslösung |
| 65920 | | 01 | | Empliciti 300 mg | | Pulver zur Herstellung einer Infusionslösung | | L01XC23 | | Elotuzumab | | 06.06.2016 | | |
|
| Composition |
| elotuzumabum 300 mg, natrii citras dihydricus corresp. natrium 3.9 mg, acidum citricum monohydricum, saccharum, polysorbatum 80 pro vitro. |
| Packungsbestandteile |
| Lyophilisate | | | | | | | | Active Agent | Dose |
|---|
| Elotuzumabum | 300 mg |
| | BAG: Active Agent | Dose |
|---|
| Elotuzumabum | 300 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Natrii Citras Dihydricus | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 1002.54 | 1106.75 | A | SL | No |
|
